{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:26:12Z","timestamp":1792797972949,"version":"4.5.0"},"reference-count":302,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02946-4","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:01:55Z","timestamp":1790290915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1382-0262","authenticated-orcid":false,"given":"Rasit","family":"Dinc","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2726-7990","authenticated-orcid":false,"given":"Nurittin","family":"Ardic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,25]]},"reference":[{"key":"2946_CR1","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/pharmaceutics15061630","volume":"15","author":"A Ahmad","year":"2023","unstructured":"Ahmad, A., Imran, M. & Ahsan, H. Biomarkers as biomedical bioindicators: approaches and techniques for the detection, analysis, and validation of novel biomarkers of diseases. Pharmaceutics 15, 1630 (2023).","journal-title":"Pharmaceutics"},{"key":"2946_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1878-5085-4-7","volume":"4","author":"E Drucker","year":"2013","unstructured":"Drucker, E. & Krapfenbauer, K. Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine. EPMA J. 4, 7 (2013).","journal-title":"EPMA J."},{"key":"2946_CR3","doi-asserted-by":"publisher","first-page":"1633487","DOI":"10.3389\/fpubh.2025.1633487","volume":"13","author":"Q Zhao","year":"2025","unstructured":"Zhao, Q. et al. Applications and challenges of biomarker-based predictive models in proactive health management. Front. Public Health 13, 1633487 (2025).","journal-title":"Front. Public Health"},{"key":"2946_CR4","doi-asserted-by":"publisher","first-page":"e124","DOI":"10.1371\/journal.pmed.0020124","volume":"2","author":"JP Ioannidis","year":"2005","unstructured":"Ioannidis, J. P. Why most published research findings are false. PLoS Med. 2, e124 (2005).","journal-title":"PLoS Med."},{"key":"2946_CR5","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai, N., Gillette, M. A. & Carr, S. A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat. Biotechnol. 24, 971\u2013983 (2006).","journal-title":"Nat. Biotechnol."},{"key":"2946_CR6","doi-asserted-by":"publisher","first-page":"791","DOI":"10.4103\/ijcm.ijcm_601_23","volume":"49","author":"Y AbdulRaheem","year":"2024","unstructured":"AbdulRaheem, Y. Statistical significance versus clinical relevance: key considerations in interpretation medical research data. Indian J. Community Med. 49, 791\u2013795 (2024).","journal-title":"Indian J. Community Med."},{"key":"2946_CR7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1681\/ASN.2013121300","volume":"25","author":"CR Parikh","year":"2014","unstructured":"Parikh, C. R. & Thiessen-Philbrook, H. Key concepts and limitations of statistical methods for evaluating biomarkers of kidney disease. J. Am. Soc. Nephrol. 25, 1621\u20131629 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"2946_CR8","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1111\/j.1742-1241.2010.02469.x","volume":"64","author":"NR Cook","year":"2010","unstructured":"Cook, N. R. Methods for evaluating novel biomarkers: a new paradigm. Int. J. Clin. Pract. 64, 1723\u20131727 (2010).","journal-title":"Int. J. Clin. Pract."},{"key":"2946_CR9","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/469156a","volume":"469","author":"G Poste","year":"2011","unstructured":"Poste, G. Bring on the biomarkers. Nature 469, 156\u2013157 (2011).","journal-title":"Nature"},{"key":"2946_CR10","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"2946_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1215-1","volume":"18","author":"Y Hasin","year":"2017","unstructured":"Hasin, Y., Seldin, M. & Lusis, A. Multi-omics approaches to disease. Genome Biol. 18, 83 (2017).","journal-title":"Genome Biol."},{"key":"2946_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1148\/radiol.2015151169","volume":"278","author":"RJ Gillies","year":"2016","unstructured":"Gillies, R. J., Kinahan, P. E. & Hricak, H. Radiomics: images are more than pictures, they are data. Radiology 278, 563\u2013577 (2016).","journal-title":"Radiology"},{"key":"2946_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ejca.2011.11.036","volume":"48","author":"P Lambin","year":"2012","unstructured":"Lambin, P. et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur. J. Cancer 48, 441\u2013446 (2012).","journal-title":"Eur. J. Cancer"},{"key":"2946_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJ Aerts","year":"2014","unstructured":"Aerts, H. J. et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat. Commun. 5, 4006 (2014).","journal-title":"Nat. Commun."},{"key":"2946_CR15","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/sim.8796","volume":"40","author":"W Fu","year":"2021","unstructured":"Fu, W., Ding, J., Gao, K., Ma, S. & Tian, L. A likelihood ratio test on temporal trends in age-period-cohort models with applications to the disparities of heart disease mortality among US populations and comparison with Japan. Stat. Med. 40, 668\u2013689 (2021).","journal-title":"Stat. Med."},{"key":"2946_CR16","doi-asserted-by":"publisher","first-page":"bbab482","DOI":"10.1093\/bib\/bbab482","volume":"23","author":"K Bu","year":"2022","unstructured":"Bu, K. et al. Identifying correlations driven by influential observations in large datasets. Brief. Bioinform. 23, bbab482 (2022).","journal-title":"Brief. Bioinform."},{"key":"2946_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/rheumato5040017","volume":"5","author":"OA Al-Ewaidat","year":"2025","unstructured":"Al-Ewaidat, O. A. & Naffaa, M. M. Emerging AI- and biomarker-driven precision medicine in autoimmune rheumatic diseases: from diagnostics to therapeutic decision-making. Rheumato 5, 17 (2025).","journal-title":"Rheumato"},{"key":"2946_CR18","doi-asserted-by":"publisher","first-page":"e70169","DOI":"10.1002\/mco2.70169","volume":"6","author":"A Awari","year":"2025","unstructured":"Awari, A. et al. Obesity biomarkers: exploring factors, ramification, machine learning, and AI-unveiling insights in health research. MedComm 6, e70169 (2025).","journal-title":"MedComm"},{"key":"2946_CR19","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1038\/s41591-025-03849-7","volume":"31","author":"M Carletti","year":"2025","unstructured":"Carletti, M. et al. Multimodal AI correlates of glucose spikes in people with normal glucose regulation, pre-diabetes and type 2 diabetes. Nat. Med. 31, 3121\u20133127 (2025).","journal-title":"Nat. Med."},{"key":"2946_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41591-021-01614-0","volume":"28","author":"P Rajpurkar","year":"2022","unstructured":"Rajpurkar, P., Chen, E., Banerjee, O. & Topol, E. J. AI in health and medicine. Nat. Med. 28, 31\u201338 (2022).","journal-title":"Nat. Med."},{"key":"2946_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44\u201356 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR22","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1038\/s41591-020-1041-y","volume":"26","author":"B Norgeot","year":"2020","unstructured":"Norgeot, B. et al. Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist. Nat. Med. 26, 1320\u20131324 (2020).","journal-title":"Nat. Med."},{"key":"2946_CR23","doi-asserted-by":"publisher","first-page":"E14","DOI":"10.1038\/s41586-020-2766-y","volume":"586","author":"B Haibe-Kains","year":"2020","unstructured":"Haibe-Kains, B. et al. Transparency and reproducibility in artificial intelligence. Nature 586, E14\u2013E16 (2020).","journal-title":"Nature"},{"key":"2946_CR24","doi-asserted-by":"publisher","first-page":"3248","DOI":"10.1007\/s12350-022-02994-7","volume":"29","author":"MA Diniz","year":"2022","unstructured":"Diniz, M. A. Statistical methods for validation of predictive models. J. Nucl. Cardiol. 29, 3248\u20133255 (2022).","journal-title":"J. Nucl. Cardiol."},{"key":"2946_CR25","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers, A. J. & Elkin, E. B. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Mak. 26, 565\u2013574 (2006).","journal-title":"Med. Decis. Mak."},{"key":"2946_CR26","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/nature08494","volume":"461","author":"TA Manolio","year":"2009","unstructured":"Manolio, T. A. et al. Finding the missing heritability of complex diseases. Nature 461, 747\u2013753 (2009).","journal-title":"Nature"},{"key":"2946_CR27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41569-021-00638-w","volume":"19","author":"D Klarin","year":"2022","unstructured":"Klarin, D. & Natarajan, P. Clinical utility of polygenic risk scores for coronary artery disease. Nat. Rev. Cardiol. 19, 291\u2013301 (2022).","journal-title":"Nat. Rev. Cardiol."},{"key":"2946_CR28","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature14248","volume":"518","author":"Roadmap Epigenomics Consortium et al.","year":"2015","unstructured":"Roadmap Epigenomics Consortium et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317\u2013330 (2015).","journal-title":"Nature"},{"key":"2946_CR29","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11708","volume":"491","author":"JK Nicholson","year":"2012","unstructured":"Nicholson, J. K. et al. Metabolic phenotyping in clinical and surgical environments. Nature 491, 384\u2013392 (2012).","journal-title":"Nature"},{"key":"2946_CR30","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3390\/molecules29102198","volume":"29","author":"C Lin","year":"2024","unstructured":"Lin, C. et al. Metabolomics for clinical biomarker discovery and therapeutic target identification. Molecules 29, 2198 (2024).","journal-title":"Molecules"},{"key":"2946_CR31","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-023-01399-3","volume":"8","author":"S Qiu","year":"2023","unstructured":"Qiu, S. et al. Small molecule metabolites: discovery of biomarkers and therapeutic targets. Signal Transduct. Target. Ther. 8, 132 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2946_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gutjnl-2023-331740","volume":"74","author":"S Ghosh","year":"2025","unstructured":"Ghosh, S., Zhao, X., Alim, M., Brudno, M. & Bhat, M. Artificial intelligence applied to \u2018omics data in liver disease: towards a personalised approach for diagnosis, prognosis and treatment. Gut 74, 295\u2013311 (2025).","journal-title":"Gut"},{"key":"2946_CR33","doi-asserted-by":"publisher","first-page":"i446","DOI":"10.1093\/bioinformatics\/btz342","volume":"35","author":"A Cheerla","year":"2019","unstructured":"Cheerla, A. & Gevaert, O. Deep learning with multimodal representation for pancancer prognosis prediction. Bioinformatics 35, i446\u2013i454 (2019).","journal-title":"Bioinformatics"},{"key":"2946_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07113-x","volume":"23","author":"I Ahmed","year":"2025","unstructured":"Ahmed, I. et al. Plasma multi-omics and machine learning reveal predictive biomarkers for type 2 diabetes and retinopathy in Qatar Biobank Cohort. J. Transl. Med. 23, 1159 (2025).","journal-title":"J. Transl. Med."},{"key":"2946_CR35","first-page":"131","volume":"54","author":"J Liu","year":"2025","unstructured":"Liu, J. et al. The role of multi-omics in biomarker discovery, diagnosis, prognosis, and therapeutic monitoring of tissue repair and regeneration processes. J. Orthop. Transl. 54, 131\u2013151 (2025).","journal-title":"J. Orthop. Transl."},{"key":"2946_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41582-023-00809-y","volume":"19","author":"M Piwecka","year":"2023","unstructured":"Piwecka, M., Rajewsky, N. & Rybak-Wolf, A. Single-cell and spatial transcriptomics: deciphering brain complexity in health and disease. Nat. Rev. Neurol. 19, 346\u2013362 (2023).","journal-title":"Nat. Rev. Neurol."},{"key":"2946_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold, R. & Mann, M. Mass-spectrometric exploration of proteome structure and function. Nature 537, 347\u2013355 (2016).","journal-title":"Nature"},{"key":"2946_CR38","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41576-019-0093-7","volume":"20","author":"T Stuart","year":"2019","unstructured":"Stuart, T. & Satija, R. Integrative single-cell analysis. Nat. Rev. Genet. 20, 257\u2013272 (2019).","journal-title":"Nat. Rev. Genet."},{"key":"2946_CR39","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41571-025-01003-3","volume":"22","author":"E Boxer","year":"2025","unstructured":"Boxer, E. et al. Emerging clinical applications of single-cell RNA sequencing in oncology. Nat. Rev. Clin. Oncol. 22, 315\u2013326 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2946_CR40","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ccell.2024.08.005","volume":"42","author":"I Tirosh","year":"2024","unstructured":"Tirosh, I. & Suv\u00e0, M. L. Cancer cell states: lessons from ten years of single-cell RNA-sequencing of human tumors. Cancer Cell 42, 1497\u20131506 (2024).","journal-title":"Cancer Cell"},{"key":"2946_CR41","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov, V. et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat. Biotechnol. 40, 661\u2013671 (2022).","journal-title":"Nat. Biotechnol."},{"key":"2946_CR42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-biodatasci-102523-103640","volume":"7","author":"FS Dezem","year":"2024","unstructured":"Dezem, F. S., Arjumand, W., DuBose, H., Morosini, N. S. & Plummer, J. Spatially resolved single-cell omics: methods, challenges, and future perspectives. Annu. Rev. Biomed. Data Sci. 7, 131\u2013153 (2024).","journal-title":"Annu. Rev. Biomed. Data Sci."},{"key":"2946_CR43","doi-asserted-by":"publisher","first-page":"100723","DOI":"10.1016\/j.xgen.2024.100723","volume":"4","author":"J De Jonghe","year":"2024","unstructured":"De Jonghe, J. et al. scTrends: a living review of commercial single-cell and spatial \u2018omic technologies. Cell Genom. 4, 100723 (2024).","journal-title":"Cell Genom."},{"key":"2946_CR44","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.tig.2025.05.002","volume":"41","author":"Y Si","year":"2025","unstructured":"Si, Y., Lee, J. S., Jun, G., Kang, H. M. & Lee, J. H. Spatial omics enters the microscopic arena: opportunities and challenges. Trends Genet. 41, 774\u2013787 (2025).","journal-title":"Trends Genet."},{"key":"2946_CR45","doi-asserted-by":"publisher","first-page":"1809941","DOI":"10.3389\/fimmu.2026.1809941","volume":"17","author":"R Dinc","year":"2026","unstructured":"Dinc, R. & Ardic, N. Mapping the immune environment: spatiotemporal dynamics in cardiovascular events. Front. Immunol. 17, 1809941 (2026).","journal-title":"Front. Immunol."},{"key":"2946_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07091-0","volume":"23","author":"T Yiu","year":"2025","unstructured":"Yiu, T. et al. Transformative advances in single-cell omics: a comprehensive review of foundation models, multimodal integration and computational ecosystems. J. Transl. Med. 23, 1176 (2025).","journal-title":"J. Transl. Med."},{"key":"2946_CR47","doi-asserted-by":"publisher","first-page":"bbaf355","DOI":"10.1093\/bib\/bbaf355","volume":"26","author":"AR Bai\u00e3o","year":"2025","unstructured":"Bai\u00e3o, A. R. et al. A technical review of multi-omics data integration methods: from classical statistical to deep generative approaches. Brief. Bioinform. 26, bbaf355 (2025).","journal-title":"Brief. Bioinform."},{"key":"2946_CR48","doi-asserted-by":"publisher","first-page":"4099","DOI":"10.1182\/blood-2009-04-217604","volume":"114","author":"HS Robins","year":"2009","unstructured":"Robins, H. S. et al. Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells. Blood 114, 4099\u20134107 (2009).","journal-title":"Blood"},{"key":"2946_CR49","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41577-022-00787-0","volume":"23","author":"G Wigerblad","year":"2023","unstructured":"Wigerblad, G. & Kaplan, M. J. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat. Rev. Immunol. 23, 274\u2013288 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"2946_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0972","volume":"86","author":"N Ardic","year":"2025","unstructured":"Ardic, N. & Dinc, R. Relationship between neutrophil extracellular traps and venous thromboembolism: pathophysiological and therapeutic role. Br. J. Hosp. Med. 86, 1\u201315 (2025).","journal-title":"Br. J. Hosp. Med."},{"key":"2946_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60900-4","volume":"16","author":"E Busarello","year":"2025","unstructured":"Busarello, E. et al. Cell Marker Accordion: interpretable single-cell and spatial omics annotation in health and disease. Nat. Commun. 16, 5399 (2025).","journal-title":"Nat. Commun."},{"key":"2946_CR52","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMra1706174","volume":"379","author":"RB Corcoran","year":"2018","unstructured":"Corcoran, R. B. & Chabner, B. A. Application of cell-free DNA analysis to cancer treatment. N. Engl. J. Med. 379, 1754\u20131765 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2946_CR53","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan, J. C. M. et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat. Rev. Cancer 17, 223\u2013238 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"2946_CR54","doi-asserted-by":"publisher","first-page":"eaay9040","DOI":"10.1126\/science.aay9040","volume":"375","author":"D Crosby","year":"2022","unstructured":"Crosby, D. et al. Early detection of cancer. Science 375, eaay9040 (2022).","journal-title":"Science"},{"key":"2946_CR55","doi-asserted-by":"publisher","first-page":"103800","DOI":"10.1016\/j.critrevonc.2022.103800","volume":"179","author":"FQ Li","year":"2022","unstructured":"Li, F. Q. & Cui, J. W. Circulating tumor DNA-minimal residual disease: an up-and-coming nova in resectable non-small-cell lung cancer. Crit. Rev. Oncol. Hematol. 179, 103800 (2022).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"2946_CR56","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Liquid biopsy in cancer current: status, challenges and future prospects. Signal Transduct. Target. Ther. 9, 336 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2946_CR57","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1097\/MS9.0000000000002776","volume":"87","author":"Z Qureshi","year":"2025","unstructured":"Qureshi, Z. et al. Liquid biopsies for early detection and monitoring of cancer: advances, challenges, and future directions. Ann. Med. Surg. 87, 3244\u20133253 (2025).","journal-title":"Ann. Med. Surg."},{"key":"2946_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41571-024-00967-y","volume":"22","author":"K Pantel","year":"2025","unstructured":"Pantel, K. & Alix-Panabi\u00e8res, C. Minimal residual disease as a target for liquid biopsy in patients with solid tumours. Nat. Rev. Clin. Oncol. 22, 65\u201377 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2946_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00984-9","volume":"9","author":"AE Boukouris","year":"2025","unstructured":"Boukouris, A. E. et al. A comprehensive overview of minimal residual disease in the management of early-stage and locally advanced non-small cell lung cancer. NPJ Precis. Oncol. 9, 178 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"2946_CR60","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ijc.35442","volume":"157","author":"T Hoang","year":"2025","unstructured":"Hoang, T., Choi, M. K., Oh, J. H. & Kim, J. Utility of circulating tumor DNA to detect minimal residual disease in colorectal cancer: a systematic review and network meta-analysis. Int. J. Cancer 157, 722\u2013740 (2025).","journal-title":"Int. J. Cancer"},{"key":"2946_CR61","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.3390\/ijms26062486","volume":"26","author":"S Negro","year":"2025","unstructured":"Negro, S. et al. Circulating tumor DNA as a real-time biomarker for minimal residual disease and recurrence prediction in stage II colorectal cancer: a systematic review and meta-analysis. Int. J. Mol. Sci. 26, 2486 (2025).","journal-title":"Int. J. Mol. Sci."},{"key":"2946_CR62","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer, P. E., Holdt, L. M., Teupser, D. & Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol. Syst. Biol. 13, 942 (2017).","journal-title":"Mol. Syst. Biol."},{"key":"2946_CR63","doi-asserted-by":"publisher","first-page":"eabl4359","DOI":"10.1126\/sciadv.abl4359","volume":"7","author":"WE Ek","year":"2021","unstructured":"Ek, W. E., Karlsson, T., H\u00f6glund, J., Rask-Andersen, M. & Johansson, \u00c5 Causal effects of inflammatory protein biomarkers on inflammatory diseases. Sci. Adv. 7, eabl4359 (2021).","journal-title":"Sci. Adv."},{"key":"2946_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01652-1","volume":"11","author":"M Moreno-Torres","year":"2021","unstructured":"Moreno-Torres, M. et al. Factors that influence the quality of metabolomics data in in vitro cell toxicity studies: a systematic survey. Sci. Rep. 11, 22119 (2021).","journal-title":"Sci. Rep."},{"key":"2946_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","volume":"9","author":"MA Kumar","year":"2024","unstructured":"Kumar, M. A. et al. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct. Target. Ther. 9, 27 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2946_CR66","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3390\/cells15030304","volume":"15","author":"R Dinc","year":"2026","unstructured":"Dinc, R. & Ardic, N. Artificial intelligence for exosomal biomarker discovery for cardiovascular diseases: multi-omics integration, reproducibility, and translational prospects. Cells 15, 304 (2026).","journal-title":"Cells"},{"key":"2946_CR67","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh, J. A. et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J. Extracell. Vesicles 13, e12404 (2024).","journal-title":"J. Extracell. Vesicles"},{"key":"2946_CR68","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"2946_CR69","doi-asserted-by":"publisher","first-page":"1286095","DOI":"10.1080\/20013078.2017.1286095","volume":"6","author":"B Mateescu","year":"2017","unstructured":"Mateescu, B. et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA: an ISEV position paper. J. Extracell. Vesicles 6, 1286095 (2017).","journal-title":"J. Extracell. Vesicles"},{"key":"2946_CR70","doi-asserted-by":"publisher","first-page":"104620","DOI":"10.1016\/j.ebiom.2023.104620","volume":"92","author":"N Darci-Maher","year":"2023","unstructured":"Darci-Maher, N. et al. Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease. EBioMedicine 92, 104620 (2023).","journal-title":"EBioMedicine"},{"key":"2946_CR71","doi-asserted-by":"publisher","first-page":"1700704","DOI":"10.3389\/fimmu.2025.1700704","volume":"16","author":"H Li","year":"2025","unstructured":"Li, H. et al. Identification and validation of core biomarkers for sepsis: a comprehensive analysis using bioinformatics and machine learning. Front. Immunol. 16, 1700704 (2025).","journal-title":"Front. Immunol."},{"key":"2946_CR72","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.csbj.2025.06.014","volume":"27","author":"L Xu","year":"2025","unstructured":"Xu, L., Li, J. & Gong, W. Applications of machine learning-assisted extracellular vesicles analysis technology in tumor diagnosis. Comput. Struct. Biotechnol. J. 27, 2460\u20132472 (2025).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2946_CR73","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1038\/s41591-025-03780-x","volume":"31","author":"G Campanella","year":"2025","unstructured":"Campanella, G. et al. Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection. Nat. Med. 31, 3002\u20133010 (2025).","journal-title":"Nat. Med."},{"key":"2946_CR74","doi-asserted-by":"publisher","first-page":"109621","DOI":"10.1016\/j.compbiomed.2024.109621","volume":"186","author":"T Nicke","year":"2025","unstructured":"Nicke, T. et al. Tissue concepts: supervised foundation models in computational pathology. Comput. Biol. Med. 186, 109621 (2025).","journal-title":"Comput. Biol. Med."},{"key":"2946_CR75","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41591-025-04060-4","volume":"32","author":"Z Li","year":"2026","unstructured":"Li, Z. et al. AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer. Nat. Med. 32, 231\u2013244 (2026).","journal-title":"Nat. Med."},{"key":"2946_CR76","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s42256-024-00807-9","volume":"6","author":"S Pai","year":"2024","unstructured":"Pai, S. et al. Foundation model for cancer imaging biomarkers. Nat. Mach. Intell. 6, 354\u2013367 (2024).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR77","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41698-024-00534-9","volume":"8","author":"M Ligero","year":"2024","unstructured":"Ligero, M. et al. A whirl of radiomics-based biomarkers in cancer immunotherapy, why is large scale validation still lacking? NPJ Precis. Oncol. 8, 42 (2024).","journal-title":"NPJ Precis. Oncol."},{"key":"2946_CR78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000500413","volume":"3","author":"A Coravos","year":"2019","unstructured":"Coravos, A. et al. Digital medicine: a primer on measurement. Digit. Biomark. 3, 31\u201371 (2019).","journal-title":"Digit. Biomark."},{"key":"2946_CR79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41746-021-00465-w","volume":"4","author":"B Bent","year":"2021","unstructured":"Bent, B. et al. Engineering digital biomarkers of interstitial glucose from noninvasive smartwatches. NPJ Digit. Med. 4, 89 (2021).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR80","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","volume":"381","author":"MV Perez","year":"2019","unstructured":"Perez, M. V. et al. Large-scale assessment of a smartwatch to identify atrial fibrillation. N. Engl. J. Med. 381, 1909\u20131917 (2019).","journal-title":"N. Engl. J. Med."},{"key":"2946_CR81","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41746-023-00956-y","volume":"6","author":"AD Zahedani","year":"2023","unstructured":"Zahedani, A. D. et al. Digital health application integrating wearable data and behavioral patterns improves metabolic health. NPJ Digit. Med. 6, 216 (2023).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR82","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-14172-z","volume":"15","author":"X Huang","year":"2025","unstructured":"Huang, X. et al. Digital biomarkers for interstitial glucose prediction in healthy individuals using wearables and machine learning. Sci. Rep. 15, 30164 (2025).","journal-title":"Sci. Rep."},{"key":"2946_CR83","doi-asserted-by":"publisher","first-page":"e100914","DOI":"10.1136\/bmjhci-2023-100914","volume":"31","author":"AK Macias Alonso","year":"2024","unstructured":"Macias Alonso, A. K., Hirt, J., Woelfle, T., Janiaud, P. & Hemkens, L. G. Definitions of digital biomarkers: a systematic mapping of the biomedical literature. BMJ Health Care Inf. 31, e100914 (2024).","journal-title":"BMJ Health Care Inf."},{"key":"2946_CR84","doi-asserted-by":"publisher","first-page":"e61318","DOI":"10.1371\/journal.pone.0061318","volume":"8","author":"MP Menden","year":"2013","unstructured":"Menden, M. P. et al. Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS ONE 8, e61318 (2013).","journal-title":"PLoS ONE"},{"key":"2946_CR85","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00441-023-03816-z","volume":"394","author":"S Ng","year":"2023","unstructured":"Ng, S., Masarone, S., Watson, D. & Barnes, M. R. The benefits and pitfalls of machine learning for biomarker discovery. Cell Tissue Res. 394, 17\u201331 (2023).","journal-title":"Cell Tissue Res."},{"key":"2946_CR86","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nature21056","volume":"542","author":"A Esteva","year":"2017","unstructured":"Esteva, A. et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 542, 115\u2013118 (2017).","journal-title":"Nature"},{"key":"2946_CR87","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","volume":"16","author":"K Bera","year":"2019","unstructured":"Bera, K., Schalper, K. A., Rimm, D. L., Velcheti, V. & Madabhushi, A. Artificial intelligence in digital pathology: new tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 16, 703\u2013715 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2946_CR88","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s42256-024-00934-3","volume":"7","author":"T Richter","year":"2025","unstructured":"Richter, T., Bahrami, M., Xia, Y., Fischer, D. S. & Theis, F. J. Delineating the effective use of self-supervised learning in single-cell genomics. Nat. Mach. Intell. 7, 68\u201378 (2025).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR89","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","volume":"28","author":"JN Acosta","year":"2022","unstructured":"Acosta, J. N., Falcone, G. J., Rajpurkar, P. & Topol, E. J. Multimodal biomedical AI. Nat. Med. 28, 1773\u20131784 (2022).","journal-title":"Nat. Med."},{"key":"2946_CR90","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.ccell.2022.09.012","volume":"40","author":"J Lipkova","year":"2022","unstructured":"Lipkova, J. et al. Artificial intelligence for multimodal data integration in oncology. Cancer Cell 40, 1095\u20131110 (2022).","journal-title":"Cancer Cell"},{"key":"2946_CR91","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","volume":"5","author":"S Steyaert","year":"2023","unstructured":"Steyaert, S. et al. Multimodal data fusion for cancer biomarker discovery with deep learning. Nat. Mach. Intell. 5, 351\u2013362 (2023).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR92","doi-asserted-by":"publisher","first-page":"102690","DOI":"10.1016\/j.inffus.2024.102690","volume":"114","author":"F Krones","year":"2025","unstructured":"Krones, F., Marikkar, U., Parsons, G., Szmul, A. & Mahdi, A. Review of multimodal machine learning approaches in healthcare. Inf. Fusion 114, 102690 (2025).","journal-title":"Inf. Fusion"},{"key":"2946_CR93","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.ccell.2022.07.004","volume":"40","author":"RJ Chen","year":"2022","unstructured":"Chen, R. J. et al. Pan-cancer integrative histology-genomic analysis via multimodal deep learning. Cancer Cell 40, 865\u2013878.e6 (2022).","journal-title":"Cancer Cell"},{"key":"2946_CR94","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s42256-024-00974-9","volume":"7","author":"SJ Mataraso","year":"2025","unstructured":"Mataraso, S. J. et al. A machine learning approach to leveraging electronic health records for enhanced omics analysis. Nat. Mach. Intell. 7, 293\u2013306 (2025).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR95","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cell.2018.05.015","volume":"173","author":"DM Camacho","year":"2018","unstructured":"Camacho, D. M., Collins, K. M., Powers, R. K., Costello, J. C. & Collins, J. J. Next-generation machine learning for biological networks. Cell 173, 1581\u20131592 (2018).","journal-title":"Cell"},{"key":"2946_CR96","doi-asserted-by":"publisher","first-page":"145276","DOI":"10.1016\/j.ijbiomac.2025.145276","volume":"319","author":"J Lin","year":"2025","unstructured":"Lin, J. et al. Chemokine-like factor-like MARVEL transmembrane domain-containing 1 identified as a novel target protein for immune dysregulation in sepsis: a machine learning and molecular dynamics framework for diagnostic biomarkers and therapeutic exploration. Int. J. Biol. Macromol. 319, 145276 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"2946_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-022-04848-y","volume":"23","author":"W Xie","year":"2022","unstructured":"Xie, W. et al. A novel biomarker selection method combining graph neural network and gene relationships applied to microarray data. BMC Bioinforma. 23, 303 (2022).","journal-title":"BMC Bioinforma."},{"key":"2946_CR98","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1158\/2159-8290.CD-22-0787","volume":"13","author":"P Dharanipragada","year":"2023","unstructured":"Dharanipragada, P. et al. Blocking genomic instability prevents acquired resistance to MAPK inhibitor therapy in melanoma. Cancer Discov. 13, 880\u2013909 (2023).","journal-title":"Cancer Discov."},{"key":"2946_CR99","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41592-024-02523-z","volume":"22","author":"H Dalla-Torre","year":"2025","unstructured":"Dalla-Torre, H. et al. Nucleotide Transformer: building and evaluating robust foundation models for human genomics. Nat. Methods 22, 287\u2013297 (2025).","journal-title":"Nat. Methods"},{"key":"2946_CR100","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/s41592-024-02524-y","volume":"22","author":"B de Almeida","year":"2025","unstructured":"de Almeida, B., Lopez, M. & Pierrot, T. Generalized AI models for genomics applications. Nat. Methods 22, 231\u2013232 (2025).","journal-title":"Nat. Methods"},{"key":"2946_CR101","doi-asserted-by":"publisher","first-page":"nwaf028","DOI":"10.1093\/nsr\/nwaf028","volume":"12","author":"F Guo","year":"2025","unstructured":"Guo, F. et al. Foundation models in bioinformatics. Natl. Sci. Rev. 12, nwaf028 (2025).","journal-title":"Natl. Sci. Rev."},{"key":"2946_CR102","doi-asserted-by":"publisher","first-page":"eadv4414","DOI":"10.1126\/science.adv4414","volume":"387","author":"EJ Topol","year":"2025","unstructured":"Topol, E. J. Learning the language of life with AI. Science 387, eadv4414 (2025).","journal-title":"Science"},{"key":"2946_CR103","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","volume":"30","author":"E Vorontsov","year":"2024","unstructured":"Vorontsov, E. et al. A foundation model for clinical-grade computational pathology and rare cancers detection. Nat. Med. 30, 2924\u20132935 (2024).","journal-title":"Nat. Med."},{"key":"2946_CR104","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella, G. et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat. Med. 25, 1301\u20131309 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR105","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1038\/s41591-025-03982-3","volume":"31","author":"T Ding","year":"2025","unstructured":"Ding, T. et al. A multimodal whole-slide foundation model for pathology. Nat. Med. 31, 3749\u20133761 (2025).","journal-title":"Nat. Med."},{"key":"2946_CR106","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41586-024-07441-w","volume":"630","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. A whole-slide foundation model for digital pathology from real-world data. Nature 630, 181\u2013188 (2024).","journal-title":"Nature"},{"key":"2946_CR107","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-023-05881-4","volume":"616","author":"M Moor","year":"2023","unstructured":"Moor, M. et al. Foundation models for generalist medical artificial intelligence. Nature 616, 259\u2013265 (2023).","journal-title":"Nature"},{"key":"2946_CR108","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin, C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat. Mach. Intell. 1, 206\u2013215 (2019).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR109","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.csbj.2024.12.027","volume":"27","author":"A Budhkar","year":"2025","unstructured":"Budhkar, A., Song, Q., Su, J. & Zhang, X. Demystifying the black box: a survey on explainable artificial intelligence (XAI) in bioinformatics. Comput. Struct. Biotechnol. J. 27, 346\u2013359 (2025).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2946_CR110","doi-asserted-by":"publisher","first-page":"115026","DOI":"10.1016\/j.isci.2026.115026","volume":"29","author":"K Zhang","year":"2026","unstructured":"Zhang, K., Wang, D., Lin, F., Xie, J. & Zhou, W. A comprehensive review of explainable artificial intelligence in healthcare methods, evaluation, and clinical integration. iScience 29, 115026 (2026).","journal-title":"iScience"},{"key":"2946_CR111","doi-asserted-by":"publisher","first-page":"bbad453","DOI":"10.1093\/bib\/bbad453","volume":"25","author":"PA Toussaint","year":"2024","unstructured":"Toussaint, P. A. et al. Explainable artificial intelligence for omics data: a systematic mapping study. Brief. Bioinform. 25, bbad453 (2024).","journal-title":"Brief. Bioinform."},{"key":"2946_CR112","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1109\/JPROC.2021.3058954","volume":"109","author":"B Sch\u00f6lkopf","year":"2021","unstructured":"Sch\u00f6lkopf, B. et al. Toward causal representation learning. Proc. IEEE 109, 612\u2013634 (2021).","journal-title":"Proc. IEEE"},{"key":"2946_CR113","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2202\/1557-4679.1203","volume":"6","author":"J Pearl","year":"2010","unstructured":"Pearl, J. An introduction to causal inference. Int. J. Biostat. 6, 7 (2010).","journal-title":"Int. J. Biostat."},{"key":"2946_CR114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1042\/ETLS20243003","volume":"8","author":"H Javaid","year":"2025","unstructured":"Javaid, H. et al. The impact of artificial intelligence on biomarker discovery. Emerg. Top. Life Sci. 8, 89\u2013105 (2025).","journal-title":"Emerg. Top. Life Sci."},{"key":"2946_CR115","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/sim.4780080407","volume":"8","author":"RL Prentice","year":"1989","unstructured":"Prentice, R. L. Surrogate endpoints in clinical trials: definition and operational criteria. Stat. Med. 8, 431\u2013440 (1989).","journal-title":"Stat. Med."},{"key":"2946_CR116","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-020-03915-6","volume":"22","author":"S Gao","year":"2021","unstructured":"Gao, S. et al. Modeling drug mechanism of action with large scale gene-expression profiles using GPAR, an artificial intelligence platform. BMC Bioinforma. 22, 17 (2021).","journal-title":"BMC Bioinforma."},{"key":"2946_CR117","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3389\/fphys.2015.00383","volume":"6","author":"MA Garc\u00eda-Campos","year":"2015","unstructured":"Garc\u00eda-Campos, M. A., Espinal-Enr\u00edquez, J. & Hern\u00e1ndez-Lemus, E. Pathway analysis: state of the art. Front. Physiol. 6, 383 (2015).","journal-title":"Front. Physiol."},{"key":"2946_CR118","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3389\/fgene.2019.01203","volume":"10","author":"S Mubeen","year":"2019","unstructured":"Mubeen, S. et al. The impact of pathway database choice on statistical enrichment analysis and predictive modeling. Front. Genet. 10, 1203 (2019).","journal-title":"Front. Genet."},{"key":"2946_CR119","doi-asserted-by":"publisher","first-page":"100672","DOI":"10.1016\/j.xgen.2024.100672","volume":"4","author":"JL Zhou","year":"2024","unstructured":"Zhou, J. L. et al. Analysis of single-cell CRISPR perturbations indicates that enhancers predominantly act multiplicatively. Cell Genom. 4, 100672 (2024).","journal-title":"Cell Genom."},{"key":"2946_CR120","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.3390\/genes16121439","volume":"16","author":"A Bjerregaard","year":"2025","unstructured":"Bjerregaard, A., Prada-Luengo, I., Das, V. & Krogh, A. What do single-cell models already know about perturbations? Genes 16, 1439 (2025).","journal-title":"Genes"},{"key":"2946_CR121","doi-asserted-by":"publisher","first-page":"bbaf277","DOI":"10.1093\/bib\/bbaf277","volume":"26","author":"OA Egbon","year":"2025","unstructured":"Egbon, O. A., Hickey, J. W. & Anchang, B. Fusion of spatiotemporal and network models to prioritize multiscale effects in single-cell perturbations. Brief. Bioinform. 26, bbaf277 (2025).","journal-title":"Brief. Bioinform."},{"key":"2946_CR122","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/cimb47050301","volume":"47","author":"VV Kleandrova","year":"2025","unstructured":"Kleandrova, V. V., Cordeiro, M. N. D. S. & Speck-Planche, A. Perturbation-theory machine learning for multi-target drug discovery in modern anticancer research. Curr. Issues Mol. Biol. 47, 301 (2025).","journal-title":"Curr. Issues Mol. Biol."},{"key":"2946_CR123","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith, G. & Hemani, G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum. Mol. Genet. 23, R89\u2013R98 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"2946_CR124","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1109\/TCYB.2022.3223783","volume":"54","author":"Z Mo","year":"2024","unstructured":"Mo, Z., Zhang, Z., Miao, Q. & Tsui, K. L. Sparsity-constrained invariant risk minimization for domain generalization with application to machinery fault diagnosis modeling. IEEE Trans. Cybern. 54, 1547\u20131559 (2024).","journal-title":"IEEE Trans. Cybern."},{"key":"2946_CR125","doi-asserted-by":"publisher","first-page":"100655","DOI":"10.1016\/j.xgen.2024.100655","volume":"4","author":"S Ni","year":"2024","unstructured":"Ni, S. et al. Identifying compound-protein interactions with knowledge graph embedding of perturbation transcriptomics. Cell Genom. 4, 100655 (2024).","journal-title":"Cell Genom."},{"key":"2946_CR126","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1093\/icb\/icab183","volume":"61","author":"E Crespi","year":"2022","unstructured":"Crespi, E. et al. Resolving the rules of robustness and resilience in biology across scales. Integr. Comp. Biol. 61, 2163\u20132179 (2022).","journal-title":"Integr. Comp. Biol."},{"key":"2946_CR127","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1039\/C5IB00031A","volume":"7","author":"LB Wood","year":"2015","unstructured":"Wood, L. B., Winslow, A. R. & Strasser, S. D. Systems biology of neurodegenerative diseases. Integr. Biol. 7, 758\u2013775 (2015).","journal-title":"Integr. Biol."},{"key":"2946_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-025-00758-2","volume":"13","author":"A Ocana","year":"2025","unstructured":"Ocana, A. Integrating artificial intelligence in drug discovery and early drug development: a transformative approach. Biomark. Res. 13, 45 (2025).","journal-title":"Biomark. Res."},{"key":"2946_CR129","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.ccell.2025.03.029","volume":"43","author":"G Arango-Argoty","year":"2025","unstructured":"Arango-Argoty, G. et al. AI-driven predictive biomarker discovery with contrastive learning to improve clinical trial outcomes. Cancer Cell 43, 875\u2013890.e8 (2025).","journal-title":"Cancer Cell"},{"key":"2946_CR130","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378 (2024).","journal-title":"BMJ"},{"key":"2946_CR131","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","volume":"54","author":"P Libby","year":"2009","unstructured":"Libby, P., Ridker, P. M. & Hansson, G. K. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 54, 2129\u20132138 (2009).","journal-title":"J. Am. Coll. Cardiol."},{"key":"2946_CR132","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.immuni.2017.02.006","volume":"46","author":"GS Firestein","year":"2017","unstructured":"Firestein, G. S. & McInnes, I. B. Immunopathogenesis of rheumatoid arthritis. Immunity 46, 183\u2013196 (2017).","journal-title":"Immunity"},{"key":"2946_CR133","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-022-01102-1","volume":"14","author":"E Fountzilas","year":"2022","unstructured":"Fountzilas, E., Tsimberidou, A. M., Vo, H. H. & Kurzrock, R. Clinical trial design in the era of precision medicine. Genome Med. 14, 101 (2022).","journal-title":"Genome Med."},{"key":"2946_CR134","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.trecan.2016.10.013","volume":"2","author":"JT J\u00f8rgensen","year":"2016","unstructured":"J\u00f8rgensen, J. T. Companion and complementary diagnostics: clinical and regulatory perspectives. Trends Cancer 2, 706\u2013712 (2016).","journal-title":"Trends Cancer"},{"key":"2946_CR135","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1158\/0008-5472.CAN-12-3232","volume":"72","author":"SE Kern","year":"2012","unstructured":"Kern, S. E. Why your new cancer biomarker may never work: recurrent patterns and remarkable diversity in biomarker failures. Cancer Res. 72, 6097\u20136101 (2012).","journal-title":"Cancer Res."},{"key":"2946_CR136","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41571-025-01011-3","volume":"22","author":"SM Ernst","year":"2025","unstructured":"Ernst, S. M. et al. Utilizing ctDNA to discover mechanisms of resistance to targeted therapies in patients with metastatic NSCLC: towards more informative trials. Nat. Rev. Clin. Oncol. 22, 371\u2013378 (2025).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2946_CR137","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nri.2017.105","volume":"18","author":"V Papayannopoulos","year":"2018","unstructured":"Papayannopoulos, V. Neutrophil extracellular traps in immunity and disease. Nat. Rev. Immunol. 18, 134\u2013147 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"2946_CR138","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol. 21, 319\u2013329 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"2946_CR139","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1056\/NEJMc2104626","volume":"385","author":"SG Finlayson","year":"2021","unstructured":"Finlayson, S. G. et al. The clinician and dataset shift in artificial intelligence. N. Engl. J. Med. 385, 283\u2013286 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2946_CR140","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s42256-021-00307-0","volume":"3","author":"M Roberts","year":"2021","unstructured":"Roberts, M. et al. Common pitfalls and recommendations for using machine learning to detect and prognosticate for COVID-19 using chest radiographs and CT scans. Nat. Mach. Intell. 3, 199\u2013217 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR141","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.fmre.2022.07.011","volume":"2","author":"S Tang","year":"2022","unstructured":"Tang, S., Yuan, K. & Chen, L. Molecular biomarkers, network biomarkers, and dynamic network biomarkers for diagnosis and prediction of rare diseases. Fundam. Res. 2, 894\u2013902 (2022).","journal-title":"Fundam. Res."},{"key":"2946_CR142","doi-asserted-by":"publisher","unstructured":"Qu, N. et al. Multimodal interpretable deep learning for transcriptome-informed precision oncology and drug mechanism analysis. NPJ Digit. Med. https:\/\/doi.org\/10.1038\/s41746-026-02735-x (2026).","DOI":"10.1038\/s41746-026-02735-x"},{"key":"2946_CR143","doi-asserted-by":"publisher","first-page":"117793221989905","DOI":"10.1177\/1177932219899051","volume":"14","author":"I Subramanian","year":"2020","unstructured":"Subramanian, I., Verma, S., Kumar, S., Jere, A. & Anamika, K. Multi-omics data integration, interpretation, and its application. Bioinform. Biol. Insights 14, 1177932219899051 (2020).","journal-title":"Bioinform. Biol. Insights"},{"key":"2946_CR144","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.csbj.2022.12.022","volume":"21","author":"G Galindez","year":"2022","unstructured":"Galindez, G., Sadegh, S., Baumbach, J., Kacprowski, T. & List, M. Network-based approaches for modeling disease regulation and progression. Comput. Struct. Biotechnol. J. 21, 780\u2013795 (2022).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2946_CR145","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41392-026-02631-6","volume":"11","author":"Y Liu","year":"2026","unstructured":"Liu, Y., Zhu, K., Peng, W., Liu, Z. & Mao, X. Multi-omics and artificial intelligence for precision drug discovery and potential clinical applications. Signal Transduct. Target. Ther. 11, 210 (2026).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2946_CR146","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-026-01287-1","volume":"19","author":"A Ben-Jaafar","year":"2026","unstructured":"Ben-Jaafar, A. et al. Artificial intelligence-based biomarkers for the diagnosis and treatment of neurological conditions: a narrative review. Mol. Brain 19, 26 (2026).","journal-title":"Mol. Brain"},{"key":"2946_CR147","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","volume":"388","author":"KGM Moons","year":"2025","unstructured":"Moons, K. G. M. et al. PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods. BMJ 388, e082505 (2025).","journal-title":"BMJ"},{"key":"2946_CR148","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41416-024-02706-7","volume":"131","author":"NA Valous","year":"2024","unstructured":"Valous, N. A. et al. Graph machine learning for integrated multi-omics analysis. Br. J. Cancer 131, 205\u2013211 (2024).","journal-title":"Br. J. Cancer"},{"key":"2946_CR149","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1038\/s42256-025-01069-9","volume":"7","author":"P Rodriguez-Mier","year":"2025","unstructured":"Rodriguez-Mier, P. et al. Unifying multi-sample network inference from prior knowledge and omics data with CORNETO. Nat. Mach. Intell. 7, 1168\u20131186 (2025).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR150","doi-asserted-by":"publisher","first-page":"bbae017","DOI":"10.1093\/bib\/bbae017","volume":"25","author":"K Wang","year":"2024","unstructured":"Wang, K. et al. TG468: a text graph convolutional network for predicting clinical response to immune checkpoint inhibitor therapy. Brief. Bioinform. 25, bbae017 (2024).","journal-title":"Brief. Bioinform."},{"key":"2946_CR151","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1160\/TH17-09-0630","volume":"118","author":"A Bonaventura","year":"2018","unstructured":"Bonaventura, A. et al. The pathophysiological role of neutrophil extracellular traps in inflammatory diseases. Thromb. Haemost. 118, 6\u201327 (2018).","journal-title":"Thromb. Haemost."},{"key":"2946_CR152","doi-asserted-by":"publisher","first-page":"100882","DOI":"10.1016\/j.crmeth.2024.100882","volume":"4","author":"J Marsiglia","year":"2024","unstructured":"Marsiglia, J. Computationally guided high-throughput engineering of an anti-CRISPR protein for precise genome editing in human cells. Cell Rep. Methods 4, 100882 (2024).","journal-title":"Cell Rep. Methods"},{"key":"2946_CR153","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster, B., McLernon, D. J., van Smeden, M., Wynants, L. & Steyerberg, E. W. Calibration: the Achilles heel of predictive analytics. BMC Med. 17, 230 (2019).","journal-title":"BMC Med."},{"key":"2946_CR154","doi-asserted-by":"crossref","unstructured":"Piovani, D., Sokou, R., Tsantes, A. G., Vitello, A. S., & Bonovas, S. Optimizing clinical decision making with decision curve analysis: insights for clinical investigators. Healthcare 11, 2244 (2023).","DOI":"10.3390\/healthcare11162244"},{"key":"2946_CR155","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1002\/sim.7992","volume":"38","author":"RD Riley","year":"2019","unstructured":"Riley, R. D. et al. Minimum sample size for developing a multivariable prediction model: PART II\u2014binary and time-to-event outcomes. Stat. Med. 38, 1276\u20131296 (2019).","journal-title":"Stat. Med."},{"key":"2946_CR156","doi-asserted-by":"publisher","first-page":"e048008","DOI":"10.1136\/bmjopen-2020-048008","volume":"11","author":"GS Collins","year":"2021","unstructured":"Collins, G. S. et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open 11, e048008 (2021).","journal-title":"BMJ Open"},{"key":"2946_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39521-2","volume":"14","author":"YJ van de Vegte","year":"2023","unstructured":"van de Vegte, Y. J. et al. Genetic insights into resting heart rate and its role in cardiovascular disease. Nat. Commun. 14, 4646 (2023).","journal-title":"Nat. Commun."},{"key":"2946_CR158","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118\u2013127 (2007).","journal-title":"Biostatistics"},{"key":"2946_CR159","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/nrg2825","volume":"11","author":"JT Leek","year":"2010","unstructured":"Leek, J. T. et al. Tackling the widespread and critical impact of batch effects in high-throughput data. Nat. Rev. Genet. 11, 733\u2013739 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"2946_CR160","doi-asserted-by":"publisher","first-page":"e26708","DOI":"10.1002\/hbm.26708","volume":"45","author":"F Hu","year":"2024","unstructured":"Hu, F. et al. DeepComBat: a statistically motivated, hyperparameter-robust, deep learning approach to harmonization of neuroimaging data. Hum. Brain Mapp. 45, e26708 (2024).","journal-title":"Hum. Brain Mapp."},{"key":"2946_CR161","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.neuroimage.2017.11.024","volume":"167","author":"JP Fortin","year":"2018","unstructured":"Fortin, J. P. et al. Harmonization of cortical thickness measurements across scanners and sites. Neuroimage 167, 104\u2013120 (2018).","journal-title":"Neuroimage"},{"key":"2946_CR162","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1001\/jamainternmed.2021.2626","volume":"181","author":"A Wong","year":"2021","unstructured":"Wong, A. et al. External validation of a widely implemented proprietary sepsis prediction model in hospitalized patients. JAMA Intern. Med. 181, 1065\u20131070 (2021).","journal-title":"JAMA Intern. Med."},{"key":"2946_CR163","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41512-022-00126-w","volume":"6","author":"P Dhiman","year":"2022","unstructured":"Dhiman, P. et al. Risk of bias of prognostic models developed using machine learning: a systematic review in oncology. Diagn. Progn. Res. 6, 13 (2022).","journal-title":"Diagn. Progn. Res."},{"key":"2946_CR164","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.euprot.2015.08.001","volume":"9","author":"B Hern\u00e1ndez","year":"2015","unstructured":"Hern\u00e1ndez, B., Pennington, S. R. & Parnell, A. C. Bayesian methods for proteomic biomarker development. EuPA Open Proteom. 9, 54\u201364 (2015).","journal-title":"EuPA Open Proteom."},{"key":"2946_CR165","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34945-8","volume":"13","author":"H Olsson","year":"2022","unstructured":"Olsson, H. et al. Estimating diagnostic uncertainty in artificial intelligence assisted pathology using conformal prediction. Nat. Commun. 13, 7761 (2022).","journal-title":"Nat. Commun."},{"key":"2946_CR166","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40264-015-0388-3","volume":"39","author":"S Seabroke","year":"2016","unstructured":"Seabroke, S. et al. Performance of stratified and subgrouped disproportionality analyses in spontaneous databases. Drug Saf. 39, 355\u2013364 (2016).","journal-title":"Drug Saf."},{"key":"2946_CR167","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/molbev\/msy118","volume":"35","author":"CAM Russo","year":"2018","unstructured":"Russo, C. A. M. & Selvatti, A. P. Bootstrap and rogue identification tests for phylogenetic analyses. Mol. Biol. Evol. 35, 2327\u20132333 (2018).","journal-title":"Mol. Biol. Evol."},{"key":"2946_CR168","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.molonc.2014.10.004","volume":"9","author":"DF Hayes","year":"2015","unstructured":"Hayes, D. F. Biomarker validation and testing. Mol. Oncol. 9, 960\u2013966 (2015).","journal-title":"Mol. Oncol."},{"key":"2946_CR169","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jtho.2021.01.1616","volume":"16","author":"FS Ou","year":"2021","unstructured":"Ou, F. S., Michiels, S., Shyr, Y., Adjei, A. A. & Oberg, A. L. Biomarker discovery and validation: statistical considerations. J. Thorac. Oncol. 16, 537\u2013545 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"2946_CR170","doi-asserted-by":"publisher","first-page":"e070904","DOI":"10.1136\/bmj-2022-070904","volume":"377","author":"B Vasey","year":"2022","unstructured":"Vasey, B. et al. Reporting guideline for the early stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. BMJ 377, e070904 (2022).","journal-title":"BMJ"},{"key":"2946_CR171","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.1665","volume":"28","author":"L Shi","year":"2010","unstructured":"Shi, L. et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28, 827\u2013838 (2010).","journal-title":"Nat. Biotechnol."},{"key":"2946_CR172","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/nbt1239","volume":"24","author":"MAQC Consortium","year":"2006","unstructured":"MAQC Consortium The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24, 1151\u20131161 (2006).","journal-title":"Nat. Biotechnol."},{"key":"2946_CR173","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt.2957","volume":"32","author":"SEQC\/MAQC-III Consortium","year":"2014","unstructured":"SEQC\/MAQC-III Consortium A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium. Nat. Biotechnol. 32, 903\u2013914 (2014).","journal-title":"Nat. Biotechnol."},{"key":"2946_CR174","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-025-06346-3","volume":"27","author":"MA Balikci","year":"2026","unstructured":"Balikci, M. A., Njume, C. M. & Cakmak, A. BioMark: biomarker analysis tool. BMC Bioinform. 27, 42 (2026).","journal-title":"BMC Bioinform."},{"key":"2946_CR175","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1111\/biom.13481","volume":"78","author":"L Jiang","year":"2022","unstructured":"Jiang, L. et al. Utilizing stability criteria in choosing feature selection methods yields reproducible results in microbiome data. Biometrics 78, 1155\u20131167 (2022).","journal-title":"Biometrics"},{"key":"2946_CR176","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41746-025-02132-w","volume":"9","author":"A Traverso","year":"2026","unstructured":"Traverso, A. et al. Powering responsible artificial intelligence with high-quality real-world data: the S-RACE platform for scalable, multi-specialty clinical research. NPJ Digit. Med. 9, 6 (2026).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR177","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1093\/neuonc\/noaa045","volume":"22","author":"C Davatzikos","year":"2020","unstructured":"Davatzikos, C. et al. AI-based prognostic imaging biomarkers for precision neuro-oncology: the ReSPOND consortium. Neuro. Oncol. 22, 886\u2013888 (2020).","journal-title":"Neuro. Oncol."},{"key":"2946_CR178","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrc1322","volume":"4","author":"DF Ransohoff","year":"2004","unstructured":"Ransohoff, D. F. Rules of evidence for cancer molecular-marker discovery and validation. Nat. Rev. Cancer 4, 309\u2013314 (2004).","journal-title":"Nat. Rev. Cancer"},{"key":"2946_CR179","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/aje\/kwh101","volume":"159","author":"MS Pepe","year":"2004","unstructured":"Pepe, M. S., Janes, H., Longton, G., Leisenring, W. & Newcomb, P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am. J. Epidemiol. 159, 882\u2013890 (2004).","journal-title":"Am. J. Epidemiol."},{"key":"2946_CR180","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1126\/science.aax2342","volume":"366","author":"Z Obermeyer","year":"2019","unstructured":"Obermeyer, Z., Powers, B., Vogeli, C. & Mullainathan, S. Dissecting racial bias in an algorithm used to manage the health of populations. Science 366, 447\u2013453 (2019).","journal-title":"Science"},{"key":"2946_CR181","doi-asserted-by":"publisher","first-page":"598","DOI":"10.7326\/0003-4819-137-7-200210010-00011","volume":"137","author":"SA Mulherin","year":"2002","unstructured":"Mulherin, S. A. & Miller, W. C. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann. Intern. Med. 137, 598\u2013602 (2002).","journal-title":"Ann. Intern. Med."},{"key":"2946_CR182","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10676-025-09829-2","volume":"27","author":"J Hatherley","year":"2025","unstructured":"Hatherley, J. A moving target in AI-assisted decision-making: dataset shift, model updating, and the problem of update opacity. Ethics Inf. Technol. 27, 20 (2025).","journal-title":"Ethics Inf. Technol."},{"key":"2946_CR183","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","volume":"20","author":"DN Cagney","year":"2018","unstructured":"Cagney, D. N. et al. The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology. Neuro. Oncol. 20, 1162\u20131172 (2018).","journal-title":"Neuro. Oncol."},{"key":"2946_CR184","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/jamia\/ocw028","volume":"23","author":"V Agarwal","year":"2016","unstructured":"Agarwal, V. et al. Learning statistical models of phenotypes using noisy labeled training data. J. Am. Med. Inform. Assoc. 23, 1166\u20131173 (2016).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"2946_CR185","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","volume":"19","author":"JP Ioannidis","year":"2008","unstructured":"Ioannidis, J. P. Why most discovered true associations are inflated. Epidemiology 19, 640\u2013648 (2008).","journal-title":"Epidemiology"},{"key":"2946_CR186","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41746-020-00324-0","volume":"3","author":"S Benjamens","year":"2020","unstructured":"Benjamens, S., Dhunnoo, P. & Mesk\u00f3, B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. NPJ Digit. Med. 3, 118 (2020).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR187","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1177\/1535370217739629","volume":"243","author":"WB Mattes","year":"2018","unstructured":"Mattes, W. B. & Goodsaid, F. Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practice. Exp. Biol. Med. 243, 256\u2013261 (2018).","journal-title":"Exp. Biol. Med."},{"key":"2946_CR188","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s42256-022-00450-2","volume":"4","author":"BD Gallas","year":"2022","unstructured":"Gallas, B. D. et al. FDA fosters innovative approaches in research, resources, and collaboration. Nat. Mach. Intell. 4, 97\u201398 (2022).","journal-title":"Nat. Mach. Intell."},{"key":"2946_CR189","unstructured":"U.S. Food and Drug Administration. Artificial Intelligence\/Machine Learning (AI\/ML)-Based Software as a Medical Device (SaMD) Action Plan. https:\/\/www.fda.gov\/media\/145022\/download (2021)."},{"key":"2946_CR190","unstructured":"U.S. Food and Drug Administration. Marketing submission recommendations for a predetermined change control plan for artificial intelligence-enabled device software functions. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/marketing-submission-recommendations-predetermined-change-control-plan-artificial-intelligence (2025)."},{"key":"2946_CR191","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1016\/j.ymthe.2024.08.030","volume":"32","author":"Y Hu","year":"2024","unstructured":"Hu, Y., Zou, Y., Qiao, L. & Lin, L. Integrative proteomic and metabolomic elucidation of cardiomyopathy with in vivo and in vitro models and clinical samples. Mol. Ther. 32, 3288\u20133312 (2024).","journal-title":"Mol. Ther."},{"key":"2946_CR192","doi-asserted-by":"publisher","first-page":"100561","DOI":"10.1016\/j.mcpro.2023.100561","volume":"22","author":"M Babu","year":"2023","unstructured":"Babu, M. & Snyder, M. Multi-omics profiling for health. Mol. Cell. Proteom. 22, 100561 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"2946_CR193","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","volume":"392","author":"EK Oikonomou","year":"2018","unstructured":"Oikonomou, E. K. et al. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet 392, 929\u2013939 (2018).","journal-title":"Lancet"},{"key":"2946_CR194","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41591-018-0240-2","volume":"25","author":"ZI Attia","year":"2019","unstructured":"Attia, Z. I. et al. Screening for cardiac contractile dysfunction using an artificial intelligence-enabled electrocardiogram. Nat. Med. 25, 70\u201374 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR195","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12968-018-0471-x","volume":"20","author":"W Bai","year":"2018","unstructured":"Bai, W. et al. Automated cardiovascular magnetic resonance image analysis with fully convolutional networks. J. Cardiovasc. Magn. Reson. 20, 65 (2018).","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"2946_CR196","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44680-3","volume":"15","author":"AM Shah","year":"2024","unstructured":"Shah, A. M. et al. Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development. Nat. Commun. 15, 528 (2024).","journal-title":"Nat. Commun."},{"key":"2946_CR197","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41416-022-02017-9","volume":"128","author":"LG Faulkner","year":"2023","unstructured":"Faulkner, L. G., Howells, L. M., Pepper, C., Shaw, J. A. & Thomas, A. L. The utility of ctDNA in detecting minimal residual disease following curative surgery in colorectal cancer: a systematic review and meta-analysis. Br. J. Cancer 128, 297\u2013309 (2023).","journal-title":"Br. J. Cancer"},{"key":"2946_CR198","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.3390\/ijms241210230","volume":"24","author":"A Chidharla","year":"2023","unstructured":"Chidharla, A. et al. Circulating tumor DNA as a minimal residual disease assessment and recurrence risk in patients undergoing curative-intent resection with or without adjuvant chemotherapy in colorectal cancer: a systematic review and meta-analysis. Int. J. Mol. Sci. 24, 10230 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2946_CR199","doi-asserted-by":"publisher","first-page":"105109","DOI":"10.1016\/j.ebiom.2024.105109","volume":"103","author":"J Zheng","year":"2024","unstructured":"Zheng, J., Qin, C., Wang, Q., Tian, D. & Chen, Z. Circulating tumour DNA-based molecular residual disease detection in resectable cancers: a systematic review and meta-analysis. EBioMedicine 103, 105109 (2024).","journal-title":"EBioMedicine"},{"key":"2946_CR200","doi-asserted-by":"publisher","first-page":"1172108","DOI":"10.3389\/fgene.2023.1172108","volume":"14","author":"L Zhu","year":"2023","unstructured":"Zhu, L. et al. Minimal residual disease (MRD) detection in solid tumors using circulating tumor DNA: a systematic review. Front. Genet. 14, 1172108 (2023).","journal-title":"Front. Genet."},{"key":"2946_CR201","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1038\/s43018-025-00960-z","volume":"6","author":"J Mart\u00edn-Arana","year":"2025","unstructured":"Mart\u00edn-Arana, J. et al. Whole-exome tumor-agnostic ctDNA analysis enhances minimal residual disease detection and reveals relapse mechanisms in localized colon cancer. Nat. Cancer 6, 1000\u20131016 (2025).","journal-title":"Nat. Cancer"},{"key":"2946_CR202","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.annonc.2024.12.006","volume":"36","author":"B Mart\u00ednez-Castedo","year":"2025","unstructured":"Mart\u00ednez-Castedo, B. et al. Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy. Ann. Oncol. 36, 263\u2013276 (2025).","journal-title":"Ann. Oncol."},{"key":"2946_CR203","doi-asserted-by":"publisher","first-page":"e006284","DOI":"10.1136\/jitc-2022-006284","volume":"11","author":"NP Semenkovich","year":"2023","unstructured":"Semenkovich, N. P., Szymanski, J. J., Earland, N., Chauhan, P. S. & Chaudhuri, A. A. Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA. J. Immunother. Cancer 11, e006284 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"2946_CR204","doi-asserted-by":"publisher","first-page":"108528","DOI":"10.1016\/j.lungcan.2025.108528","volume":"203","author":"L Rosenlund","year":"2025","unstructured":"Rosenlund, L. et al. ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach. Lung Cancer 203, 108528 (2025).","journal-title":"Lung Cancer"},{"key":"2946_CR205","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.21037\/jgo-24-81","volume":"15","author":"C Eslinger","year":"2024","unstructured":"Eslinger, C., Wu, C. & Ahn, D. H. Minimal residual disease monitoring via ctDNA: a case report of Lynch syndrome with synchronous colorectal cancer and review of literature. J. Gastrointest. Oncol. 15, 1341\u20131347 (2024).","journal-title":"J. Gastrointest. Oncol."},{"key":"2946_CR206","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","volume":"25","author":"JN Kather","year":"2019","unstructured":"Kather, J. N. et al. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat. Med. 25, 1054\u20131056 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR207","doi-asserted-by":"publisher","first-page":"100691","DOI":"10.1016\/j.xgen.2024.100691","volume":"4","author":"L Qian","year":"2024","unstructured":"Qian, L. et al. AI-empowered perturbation proteomics for complex biological systems. Cell Genom. 4, 100691 (2024).","journal-title":"Cell Genom."},{"key":"2946_CR208","first-page":"22","volume":"9","author":"PK Sekar","year":"2025","unstructured":"Sekar, P. K. & Veerabathiran, R. Systems immunology meets clinical translation: multi-omic approaches to predict therapy response in cancer and autoimmune disease. Clin. Immunol. Commun. 9, 22 (2025).","journal-title":"Clin. Immunol. Commun."},{"key":"2946_CR209","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41591-020-0860-1","volume":"26","author":"KC Yuen","year":"2020","unstructured":"Yuen, K. C. et al. High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat. Med. 26, 693\u2013698 (2020).","journal-title":"Nat. Med."},{"key":"2946_CR210","doi-asserted-by":"publisher","first-page":"e2100181","DOI":"10.1200\/PO.21.00181","volume":"6","author":"PM Kasi","year":"2022","unstructured":"Kasi, P. M. et al. Impact of circulating tumor DNA-based detection of molecular residual disease on the conduct and design of clinical trials for solid tumors. JCO Precis. Oncol. 6, e2100181 (2022).","journal-title":"JCO Precis. Oncol."},{"key":"2946_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00876-y","volume":"9","author":"A Bartolomucci","year":"2025","unstructured":"Bartolomucci, A. et al. Circulating tumor DNA to monitor treatment response in solid tumors and advance precision oncology. NPJ Precis. Oncol. 9, 84 (2025).","journal-title":"NPJ Precis. Oncol."},{"key":"2946_CR212","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.reuma.2024.05.005","volume":"20","author":"MJ Garc\u00eda de Y\u00e9benes Prous","year":"2024","unstructured":"Garc\u00eda de Y\u00e9benes Prous, M. J. & Carmona Ortells, L. Biomarkers: how to consolidate them in clinical practice. Reumatol. Clin. 20, 386\u2013391 (2024).","journal-title":"Reumatol. Clin."},{"key":"2946_CR213","doi-asserted-by":"publisher","first-page":"3234","DOI":"10.1093\/brain\/awaa286","volume":"143","author":"N Mattsson-Carlgren","year":"2020","unstructured":"Mattsson-Carlgren, N. et al. Longitudinal plasma p-tau217 is increased in early stages of Alzheimer\u2019s disease. Brain 143, 3234\u20133241 (2020).","journal-title":"Brain"},{"key":"2946_CR214","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s43587-023-00403-3","volume":"3","author":"O Hansson","year":"2023","unstructured":"Hansson, O., Blennow, K., Zetterberg, H. & Dage, J. Blood biomarkers for Alzheimer\u2019s disease in clinical practice and trials. Nat. Aging 3, 506\u2013519 (2023).","journal-title":"Nat. Aging"},{"key":"2946_CR215","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack","year":"2018","unstructured":"Jack, C. R. et al. NIA-AA Research Framework: toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"2946_CR216","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","volume":"24","author":"A Leuzy","year":"2019","unstructured":"Leuzy, A. et al. Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge. Mol. Psychiatry 24, 1112\u20131134 (2019).","journal-title":"Mol. Psychiatry"},{"key":"2946_CR217","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1007\/s00259-020-04923-7","volume":"48","author":"EC Mormino","year":"2021","unstructured":"Mormino, E. C. et al. Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases. Eur. J. Nucl. Med. Mol. Imaging 48, 2233\u20132244 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"2946_CR218","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1109\/JBHI.2016.2636665","volume":"21","author":"D Ravi","year":"2017","unstructured":"Ravi, D. et al. Deep learning for health informatics. IEEE J. Biomed. Health Inform. 21, 4\u201321 (2017).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"2946_CR219","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target. Ther. 8, 267 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2946_CR220","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","volume":"21","author":"R van der Kant","year":"2020","unstructured":"van der Kant, R., Goldstein, L. S. B. & Ossenkoppele, R. Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease. Nat. Rev. Neurosci. 21, 21\u201335 (2020).","journal-title":"Nat. Rev. Neurosci."},{"key":"2946_CR221","doi-asserted-by":"publisher","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","volume":"1","author":"A Serrano-Pozo","year":"2011","unstructured":"Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Neuropathological alterations in Alzheimer disease. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2946_CR222","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.lanhl.2024.07.013","volume":"5","author":"M Sch\u00f6ll","year":"2024","unstructured":"Sch\u00f6ll, M. et al. Challenges in the practical implementation of blood biomarkers for Alzheimer\u2019s disease. Lancet Healthy Longev. 5, 100630 (2024).","journal-title":"Lancet Healthy Longev."},{"key":"2946_CR223","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2019.06.029","volume":"178","author":"CS Smillie","year":"2019","unstructured":"Smillie, C. S. et al. Intra- and inter-cellular rewiring of the human colon during ulcerative colitis. Cell 178, 714\u2013730.e22 (2019).","journal-title":"Cell"},{"key":"2946_CR224","doi-asserted-by":"publisher","first-page":"100820","DOI":"10.1016\/j.xgen.2025.100820","volume":"5","author":"L Wang","year":"2025","unstructured":"Wang, L. et al. An atlas of single-cell eQTLs dissects autoimmune disease genes and identifies novel drug classes for treatment. Cell Genom. 5, 100820 (2025).","journal-title":"Cell Genom."},{"key":"2946_CR225","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","volume":"69","author":"JS Smolen","year":"2010","unstructured":"Smolen, J. S. et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631\u2013637 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"2946_CR226","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","volume":"133","author":"SL Hauser","year":"2020","unstructured":"Hauser, S. L. & Cree, B. A. C. Treatment of multiple sclerosis: a review. Am. J. Med. 133, 1380\u20131390.e2 (2020).","journal-title":"Am. J. Med."},{"key":"2946_CR227","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S2468-1253(23)00159-0","volume":"8","author":"H Tilg","year":"2023","unstructured":"Tilg, H., Byrne, C. D. & Targher, G. NASH drug treatment development: challenges and lessons. Lancet Gastroenterol. Hepatol. 8, 943\u2013954 (2023).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"2946_CR228","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jhep.2024.03.035","volume":"81","author":"M Thiele","year":"2024","unstructured":"Thiele, M. et al. Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases. J. Hepatol. 81, 345\u2013359 (2024).","journal-title":"J. Hepatol."},{"key":"2946_CR229","doi-asserted-by":"publisher","first-page":"101320","DOI":"10.1016\/j.lanepe.2025.101320","volume":"54","author":"JV Lazarus","year":"2025","unstructured":"Lazarus, J. V. et al. A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis. Lancet Reg. Health Eur. 54, 101320 (2025).","journal-title":"Lancet Reg. Health Eur."},{"key":"2946_CR230","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/HEP.0000000000000542","volume":"79","author":"M Noureddin","year":"2024","unstructured":"Noureddin, M. et al. Serum identification of at-risk MASH: the metabolomics-advanced steatohepatitis fibrosis score (MASEF). Hepatology 79, 135\u2013148 (2024).","journal-title":"Hepatology"},{"key":"2946_CR231","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","volume":"65","author":"ME Rinella","year":"2024","unstructured":"Rinella, M. E. & Sookoian, S. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. J. Lipid Res. 65, 100485 (2024).","journal-title":"J. Lipid Res."},{"key":"2946_CR232","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.3390\/ijms25158462","volume":"25","author":"CM Sergi","year":"2024","unstructured":"Sergi, C. M. NAFLD (MASLD)\/NASH (MASH): does it bother to label at all? A comprehensive narrative review. Int. J. Mol. Sci. 25, 8462 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"2946_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60768-2","volume":"14","author":"IG Park","year":"2024","unstructured":"Park, I. G. et al. Gut microbiota-based machine-learning signature for the diagnosis of alcohol-associated and metabolic dysfunction-associated steatotic liver disease. Sci. Rep. 14, 16122 (2024).","journal-title":"Sci. Rep."},{"key":"2946_CR234","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","volume":"54","author":"G Sveinbjornsson","year":"2022","unstructured":"Sveinbjornsson, G. et al. A multi-omics study of non-alcoholic fatty liver disease. Nat. Genet. 54, 1652\u20131663 (2022).","journal-title":"Nat. Genet."},{"key":"2946_CR235","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48956-0","volume":"15","author":"L Verschuren","year":"2024","unstructured":"Verschuren, L. et al. Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD. Nat. Commun. 15, 4564 (2024).","journal-title":"Nat. Commun."},{"key":"2946_CR236","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56013-7","volume":"16","author":"N Stratakis","year":"2025","unstructured":"Stratakis, N. et al. Multi-omic architecture, biological pathways, and prenatal determinants of childhood obesity and metabolic dysfunction. Nat. Commun. 16, 654 (2025).","journal-title":"Nat. Commun."},{"key":"2946_CR237","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41591-025-04009-7","volume":"32","author":"RM Chakaroun","year":"2026","unstructured":"Chakaroun, R. M. et al. Multi-omic definition of metabolic obesity through adipose tissue-microbiome interactions. Nat. Med. 32, 113\u2013125 (2026).","journal-title":"Nat. Med."},{"key":"2946_CR238","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-024-01047-y","volume":"21","author":"M Sot\u00e1k","year":"2025","unstructured":"Sot\u00e1k, M., Clark, M., Suur, B. E. & B\u00f6rgeson, E. Inflammation and resolution in obesity. Nat. Rev. Endocrinol. 21, 45\u201361 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"2946_CR239","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64846-3","volume":"14","author":"T R\u00f6nn","year":"2024","unstructured":"R\u00f6nn, T., Perfilyev, A., Oskolkov, N. & Ling, C. Predicting type 2 diabetes via machine learning integration of multiple omics from human pancreatic islets. Sci. Rep. 14, 14637 (2024).","journal-title":"Sci. Rep."},{"key":"2946_CR240","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41591-023-02702-z","volume":"30","author":"L Dai","year":"2024","unstructured":"Dai, L. et al. A deep learning system for predicting time to progression of diabetic retinopathy. Nat. Med. 30, 584\u2013594 (2024).","journal-title":"Nat. Med."},{"key":"2946_CR241","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jhep.2023.07.017","volume":"80","author":"V Ratziu","year":"2024","unstructured":"Ratziu, V. et al. Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD. J. Hepatol. 80, e51\u2013e52 (2024).","journal-title":"J. Hepatol."},{"key":"2946_CR242","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-03324-6","volume":"30","author":"L Chen","year":"2025","unstructured":"Chen, L., Zhang, X. & Shi, P. Recent advances in biomarkers for detection and diagnosis of sepsis and organ dysfunction: a comprehensive review. Eur. J. Med. Res. 30, 1081 (2025).","journal-title":"Eur. J. Med. Res."},{"key":"2946_CR243","doi-asserted-by":"publisher","first-page":"154360","DOI":"10.1016\/j.jcrc.2023.154360","volume":"78","author":"AH de Nooijer","year":"2023","unstructured":"de Nooijer, A. H., Pickkers, P., Netea, M. G. & Kox, M. Inflammatory biomarkers to predict the prognosis of acute bacterial and viral infections. J. Crit. Care 78, 154360 (2023).","journal-title":"J. Crit. Care"},{"key":"2946_CR244","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-93010-8","volume":"15","author":"W Xiong","year":"2025","unstructured":"Xiong, W., Zhan, Y., Xiao, R. & Liu, F. Advancing sepsis diagnosis and immunotherapy: machine learning-driven identification of stable molecular biomarkers and therapeutic targets. Sci. Rep. 15, 8333 (2025).","journal-title":"Sci. Rep."},{"key":"2946_CR245","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-14600-0","volume":"15","author":"J Yang","year":"2025","unstructured":"Yang, J. et al. Machine learning based screening of biomarkers associated with cell death and immunosuppression of multiple life stages sepsis populations. Sci. Rep. 15, 30302 (2025).","journal-title":"Sci. Rep."},{"key":"2946_CR246","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1016\/j.jtho.2021.06.017","volume":"16","author":"C Rolfo","year":"2021","unstructured":"Rolfo, C. et al. Liquid biopsy for advanced NSCLC: a consensus statement from the International Association for the Study of Lung Cancer. J. Thorac. Oncol. 16, 1647\u20131662 (2021).","journal-title":"J. Thorac. Oncol."},{"key":"2946_CR247","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/jnci\/djy156","volume":"111","author":"JK Sabari","year":"2019","unstructured":"Sabari, J. K. et al. A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers. J. Natl. Cancer Inst. 111, 575\u2013583 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"2946_CR248","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"2946_CR249","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1038\/s41591-018-0157-9","volume":"24","author":"N Auslander","year":"2018","unstructured":"Auslander, N. et al. Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma. Nat. Med. 24, 1545\u20131549 (2018).","journal-title":"Nat. Med."},{"key":"2946_CR250","doi-asserted-by":"crossref","unstructured":"Berry, S. M., Carlin, B. P., Lee, J. J. & Muller, P. Bayesian Adaptive Methods for Clinical Trials (CRC Press, 2010).","DOI":"10.1201\/EBK1439825488"},{"key":"2946_CR251","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","volume":"16","author":"SL Topalian","year":"2016","unstructured":"Topalian, S. L., Taube, J. M., Anders, R. A. & Pardoll, D. M. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nat. Rev. Cancer 16, 275\u2013287 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"2946_CR252","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.trecan.2017.12.004","volume":"4","author":"V Subbiah","year":"2018","unstructured":"Subbiah, V. & Kurzrock, R. Challenging standard-of-care paradigms in the precision oncology era. Trends Cancer 4, 101\u2013109 (2018).","journal-title":"Trends Cancer"},{"key":"2946_CR253","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.1158\/1078-0432.CCR-25-1918","volume":"31","author":"OO Okusanya","year":"2025","unstructured":"Okusanya, O. O. et al. FDA-AACR strategies for optimizing dosages for oncology drug products: early-phase trials using innovative trial designs and biomarkers. Clin. Cancer Res. 31, 4882\u20134890 (2025).","journal-title":"Clin. Cancer Res."},{"key":"2946_CR254","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/0003-4819-125-7-199610010-00011","volume":"125","author":"TR Fleming","year":"1996","unstructured":"Fleming, T. R. & DeMets, D. L. Surrogate end points in clinical trials: are we being misled? Ann. Intern. Med. 125, 605\u2013613 (1996).","journal-title":"Ann. Intern. Med."},{"key":"2946_CR255","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1002\/sim.5403","volume":"31","author":"TR Fleming","year":"2012","unstructured":"Fleming, T. R. & Powers, J. H. Biomarkers and surrogate endpoints in clinical trials. Stat. Med. 31, 2973\u20132984 (2012).","journal-title":"Stat. Med."},{"key":"2946_CR256","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41591-023-02784-9","volume":"30","author":"M Moqri","year":"2024","unstructured":"Moqri, M. et al. Validation of biomarkers of aging. Nat. Med. 30, 360\u2013372 (2024).","journal-title":"Nat. Med."},{"key":"2946_CR257","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman, R. E. et al. Real-world evidence\u2014what is it and what can it tell us? N. Engl. J. Med. 375, 2293\u20132297 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2946_CR258","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jaccao.2022.02.002","volume":"4","author":"H Ohtsu","year":"2022","unstructured":"Ohtsu, H., Shimomura, A. & Sase, K. Real-world evidence in cardio-oncology: what is it and what can it tell us? JACC CardioOncol. 4, 95\u201397 (2022).","journal-title":"JACC CardioOncol."},{"key":"2946_CR259","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2217\/cer-2021-0296","volume":"11","author":"F Griesinger","year":"2022","unstructured":"Griesinger, F., Cox, O., Sammon, C., Ramagopalan, S. V. & Popat, S. Health technology assessments and real-world evidence: tell us what you want, what you really, really want. J. Comp. Eff. Res. 11, 297\u2013299 (2022).","journal-title":"J. Comp. Eff. Res."},{"key":"2946_CR260","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12968\/hmed.2024.0972","volume":"86","author":"N Ardic","year":"2025","unstructured":"Ardic, N. & Dinc, R. Artificial intelligence in healthcare: current regulatory landscape and future directions. Br. J. Hosp. Med. 86, 1\u201321 (2025).","journal-title":"Br. J. Hosp. Med."},{"key":"2946_CR261","unstructured":"U.S. Food and Drug Administration. Biomarker qualification: evidentiary framework. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/biomarker-qualification-evidentiary-framework (2018)."},{"key":"2946_CR262","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41746-019-0090-4","volume":"2","author":"A Coravos","year":"2019","unstructured":"Coravos, A., Khozin, S. & Mandl, K. D. Developing and adopting safe and effective digital biomarkers to improve patient outcomes. NPJ Digit. Med. 2, 14 (2019).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR263","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41591-018-0272-7","volume":"25","author":"WN Price II.","year":"2019","unstructured":"Price, W. N. II. & Cohen, I. G. Privacy in the age of medical big data. Nat. Med. 25, 37\u201343 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR264","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41591-023-02429-x","volume":"29","author":"AP Patel","year":"2023","unstructured":"Patel, A. P. et al. A multi-ancestry polygenic risk score improves risk prediction for coronary artery disease. Nat. Med. 29, 1793\u20131803 (2023).","journal-title":"Nat. Med."},{"key":"2946_CR265","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","volume":"406","author":"GBD 2023 Causes of Death Collaborators","year":"2025","unstructured":"GBD 2023 Causes of Death Collaborators Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406, 1811\u20131872 (2025).","journal-title":"Lancet"},{"key":"2946_CR266","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12672-025-02064-7","volume":"16","author":"EU Alum","year":"2025","unstructured":"Alum, E. U. AI-driven biomarker discovery: enhancing precision in cancer diagnosis and prognosis. Discov. Oncol. 16, 313 (2025).","journal-title":"Discov. Oncol."},{"key":"2946_CR267","doi-asserted-by":"publisher","first-page":"879","DOI":"10.3390\/bioengineering12080879","volume":"12","author":"Y Singh","year":"2025","unstructured":"Singh, Y. et al. Beyond post hoc explanations: a comprehensive framework for responsible artificial intelligence in medical imaging through transparency, interpretability, and explainability. Bioengineering12, 879 (2025).","journal-title":"Bioengineering"},{"key":"2946_CR268","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/483531a","volume":"483","author":"CG Begley","year":"2012","unstructured":"Begley, C. G. & Ellis, L. M. Drug development: raise standards for preclinical cancer research. Nature 483, 531\u2013533 (2012).","journal-title":"Nature"},{"key":"2946_CR269","doi-asserted-by":"publisher","first-page":"118579","DOI":"10.1016\/j.neuroimage.2021.118579","volume":"244","author":"AR Laird","year":"2021","unstructured":"Laird, A. R. Large, open datasets for human connectomics research: considerations for reproducible and responsible data use. Neuroimage 244, 118579 (2021).","journal-title":"Neuroimage"},{"key":"2946_CR270","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41746-025-01471-y","volume":"8","author":"E Fountzilas","year":"2025","unstructured":"Fountzilas, E., Pearce, T., Baysal, M. A., Chakraborty, A. & Tsimberidou, A. M. Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. NPJ Digit. Med. 8, 75 (2025).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR271","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56442-4","volume":"16","author":"KM Mendez","year":"2025","unstructured":"Mendez, K. M. et al. A roadmap to precision medicine through post-genomic electronic medical records. Nat. Commun. 16, 1700 (2025).","journal-title":"Nat. Commun."},{"key":"2946_CR272","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ccell.2025.12.009","volume":"44","author":"Y Liu","year":"2026","unstructured":"Liu, Y., Dai, Y. & Wang, L. Spatial omics at the forefront: emerging technologies, analytical innovations, and clinical applications. Cancer Cell 44, 24\u201349 (2026).","journal-title":"Cancer Cell"},{"key":"2946_CR273","doi-asserted-by":"publisher","first-page":"101105","DOI":"10.1016\/j.xgen.2025.101105","volume":"6","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y. et al. Robust integration and annotation of single-cell and spatial omics data using interpretable gene programs. Cell Genom. 6, 101105 (2025).","journal-title":"Cell Genom."},{"key":"2946_CR274","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41573-023-00688-4","volume":"22","author":"B Van de Sande","year":"2023","unstructured":"Van de Sande, B. et al. Applications of single-cell RNA sequencing in drug discovery and development. Nat. Rev. Drug Discov. 22, 496\u2013520 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2946_CR275","doi-asserted-by":"publisher","first-page":"8393990","DOI":"10.1155\/2023\/8393990","volume":"2023","author":"K Dasaradharami Reddy","year":"2023","unstructured":"Dasaradharami Reddy, K. & Gadekallu, T. R. A comprehensive survey on federated learning techniques for healthcare informatics. Comput. Intell. Neurosci. 2023, 8393990 (2023).","journal-title":"Comput. Intell. Neurosci."},{"key":"2946_CR276","doi-asserted-by":"publisher","first-page":"113075","DOI":"10.1016\/j.diabres.2025.113075","volume":"231","author":"DB Olawade","year":"2026","unstructured":"Olawade, D. B. et al. Digital twin paradigm in diabetes prediction and management. Diab. Res. Clin. Pract. 231, 113075 (2026).","journal-title":"Diab. Res. Clin. Pract."},{"key":"2946_CR277","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.ymeth.2020.01.011","volume":"185","author":"M Viceconti","year":"2021","unstructured":"Viceconti, M. et al. In silico trials: verification, validation and uncertainty quantification of predictive models used in the regulatory evaluation of biomedical products. Methods 185, 120\u2013127 (2021).","journal-title":"Methods"},{"key":"2946_CR278","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","volume":"5","author":"K Strimbu","year":"2010","unstructured":"Strimbu, K. & Tavel, J. A. What are biomarkers? Curr. Opin. HIV AIDS 5, 463\u2013466 (2010).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"2946_CR279","doi-asserted-by":"crossref","unstructured":"Chenchula, S., Paraskar, G., Krishna, S. & Chavan, M. Liquid biopsy in clinical practice: current evidence and future directions. In Liquid Biopsy in Cancer Management (eds Bhatt, S., Anitha, A., Chenchula, S. & Mishra, N.) 405\u2013438 (Academic Press, 2026).","DOI":"10.1016\/B978-0-443-27496-1.00010-5"},{"key":"2946_CR280","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.3390\/cells14242000","volume":"14","author":"S Ohara","year":"2025","unstructured":"Ohara, S. & Suda, K. Current status and future challenges of liquid biopsy. Cells 14, 2000 (2025).","journal-title":"Cells"},{"key":"2946_CR281","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","volume":"1","author":"MD Abr\u00e0moff","year":"2018","unstructured":"Abr\u00e0moff, M. D., Lavin, P. T., Birch, M., Shah, N. & Folk, J. C. Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit. Med. 1, 39 (2018).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR282","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1136\/neurintsurg-2021-017714","volume":"14","author":"L Elijovich","year":"2022","unstructured":"Elijovich, L. et al. Automated emergent large vessel occlusion detection by artificial intelligence improves stroke workflow in a hub and spoke stroke system of care. J. Neurointerv. Surg. 14, 704\u2013708 (2022).","journal-title":"J. Neurointerv. Surg."},{"key":"2946_CR283","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1016\/S0140-6736(18)31645-3","volume":"392","author":"S Chilamkurthy","year":"2018","unstructured":"Chilamkurthy, S. et al. Deep learning algorithms for detection of critical findings in head CT scans: a retrospective study. Lancet 392, 2388\u20132396 (2018).","journal-title":"Lancet"},{"key":"2946_CR284","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41591-018-0213-5","volume":"24","author":"M Komorowski","year":"2018","unstructured":"Komorowski, M., Celi, L. A., Badawi, O., Gordon, A. C. & Faisal, A. A. The Artificial Intelligence Clinician learns optimal treatment strategies for sepsis in intensive care. Nat. Med. 24, 1716\u20131720 (2018).","journal-title":"Nat. Med."},{"key":"2946_CR285","doi-asserted-by":"publisher","first-page":"6545","DOI":"10.1007\/s00330-020-06998-0","volume":"30","author":"T Weikert","year":"2020","unstructured":"Weikert, T. et al. Automated detection of pulmonary embolism in CT pulmonary angiograms using an AI-powered algorithm. Eur. Radiol. 30, 6545\u20136553 (2020).","journal-title":"Eur. Radiol."},{"key":"2946_CR286","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1001\/jama.2017.18391","volume":"319","author":"AL Beam","year":"2018","unstructured":"Beam, A. L. & Kohane, I. S. Big data and machine learning in health care. JAMA 319, 1317\u20131318 (2018).","journal-title":"JAMA"},{"key":"2946_CR287","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva, A. et al. A guide to deep learning in healthcare. Nat. Med. 25, 24\u201329 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR288","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/fampra\/cmn051","volume":"25","author":"BH Willis","year":"2008","unstructured":"Willis, B. H. Spectrum bias\u2014why clinicians need to be cautious when applying diagnostic test studies. Fam. Pract. 25, 390\u2013396 (2008).","journal-title":"Fam. Pract."},{"key":"2946_CR289","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758\u2013764 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"2946_CR290","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrn.2016.167","volume":"18","author":"RA Poldrack","year":"2017","unstructured":"Poldrack, R. A. et al. Scanning the horizon: towards transparent and reproducible neuroimaging research. Nat. Rev. Neurosci. 18, 115\u2013126 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"2946_CR291","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41591-019-0548-6","volume":"25","author":"J Wiens","year":"2019","unstructured":"Wiens, J. et al. Do no harm: a roadmap for responsible machine learning for health care. Nat. Med. 25, 1337\u20131340 (2019).","journal-title":"Nat. Med."},{"key":"2946_CR292","doi-asserted-by":"publisher","first-page":"102445","DOI":"10.1016\/j.eclinm.2024.102445","volume":"68","author":"J Kim","year":"2024","unstructured":"Kim, J. et al. Deep learning-based long-term risk evaluation of incident type 2 diabetes using electrocardiogram in a non-diabetic population: a retrospective, multicentre study. EClinicalMedicine 68, 102445 (2024).","journal-title":"EClinicalMedicine"},{"key":"2946_CR293","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41746-025-02036-9","volume":"8","author":"RA Fraser","year":"2025","unstructured":"Fraser, R. A., Walker, R. J., Campbell, J. A., Ekwunife, O. & Egede, L. E. Integration of artificial intelligence and wearable technology in the management of diabetes and prediabetes. NPJ Digit. Med. 8, 687 (2025).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR294","doi-asserted-by":"publisher","unstructured":"Lee, H. et al. External validation of ECG artificial intelligence for emergency and cardiac assessment across a large-scale U.S. healthcare system. NPJ Digit. Med. https:\/\/doi.org\/10.1038\/s41746-026-02682-7 (2026).","DOI":"10.1038\/s41746-026-02682-7"},{"key":"2946_CR295","unstructured":"FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource (Food and Drug Administration (US); FDA-NIH Biomarker Working Group, 2016)."},{"key":"2946_CR296","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jval.2016.10.011","volume":"20","author":"O Ciani","year":"2017","unstructured":"Ciani, O. et al. Time to review the role of surrogate end points in health policy: state of the art and the way forward. Value Health 20, 487\u2013495 (2017).","journal-title":"Value Health"},{"key":"2946_CR297","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.3390\/jcm12113755","volume":"12","author":"AS Chandrabhatla","year":"2023","unstructured":"Chandrabhatla, A. S. et al. Artificial intelligence and machine learning in the diagnosis and management of stroke: a narrative review of United States Food and Drug Administration-approved technologies. J. Clin. Med. 12, 3755 (2023).","journal-title":"J. Clin. Med."},{"key":"2946_CR298","doi-asserted-by":"publisher","first-page":"e76854","DOI":"10.2196\/76854","volume":"4","author":"E Carvalho","year":"2025","unstructured":"Carvalho, E. et al. Predetermined change control plans: guiding principles for advancing safe, effective, and high-quality AI-ML technologies. JMIR AI 4, e76854 (2025).","journal-title":"JMIR AI"},{"key":"2946_CR299","doi-asserted-by":"publisher","first-page":"e537","DOI":"10.1016\/S2589-7500(20)30218-1","volume":"2","author":"X Liu","year":"2020","unstructured":"Liu, X., Cruz Rivera, S., Moher, D. & Calvert, M. J. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Lancet Digit. Health 2, e537\u2013e548 (2020).","journal-title":"Lancet Digit. Health"},{"key":"2946_CR300","doi-asserted-by":"publisher","first-page":"m3210","DOI":"10.1136\/bmj.m3210","volume":"370","author":"SC Rivera","year":"2020","unstructured":"Rivera, S. C., Liu, X., Chan, A. W., Denniston, A. K. & Calvert, M. J. Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI Extension. BMJ 370, m3210 (2020).","journal-title":"BMJ"},{"key":"2946_CR301","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41746-024-01232-3","volume":"7","author":"M Aboy","year":"2024","unstructured":"Aboy, M., Minssen, T. & Vayena, E. Navigating the EU AI Act: implications for regulated digital medical products. NPJ Digit. Med. 7, 237 (2024).","journal-title":"NPJ Digit. Med."},{"key":"2946_CR302","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/hcs2.114","volume":"3","author":"H Yuan","year":"2024","unstructured":"Yuan, H. Toward real-world deployment of machine learning for health care: external validation, continual monitoring, and randomized clinical trials. Health Care Sci. 3, 360\u2013364 (2024).","journal-title":"Health Care Sci."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02946-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02946-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02946-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:02:00Z","timestamp":1790290920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02946-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,25]]},"references-count":302,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2946"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02946-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,25]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.D. is the president of the INVAMED Institute for Medical Innovation. N.A. is retired and works as a volunteer consultant for Med-International UK Health Agency Ltd.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"407"}}